An interventional study of Parenteral nutrition cycling in Cholestasis in Newborn, sponsored by Hospital Pediátrico de Sinaloa. Recruiting at 1 site in Mexico. Open to participants aged 1 Hour to 28 Days. Per ClinicalTrials.gov, last updated 2024-04-16.
Sponsored by Hospital Pediátrico de Sinaloa · Not applicable, Interventional, and Prevention
Background: Despite the use of parenteral nutrition cycling (PNC) in neonatal intensive care units (NICU), there is limited evidence regarding the benefits in relation to the nutrición parenteral total (NPT) in term and late preterm infants.
The recommendations from the recently published Latin American Society of Gastroenterology, Hepatology and Pediatric Nutrition guidelines are substantially different in this area, and surveys have reported variations in clinical practice.
The aim of this randomised controlled trial (RCT) is to evaluate the benefits and risks of PNC AND parenteral nutrition total (NPT) in term and late preterm infants.
Methods/design:
This study is a single-centre, non-blinded RCT in the NICU of Pediatric Hospital of Sinaloa, Northwest, Mexico.
A total of 66 infants born ≥34 weeks of gestation who have a high likelihood of intolerance to enteral nutrition (EN) for at least 10 days will be randomised to PNC o PNT after informed parental consent. In both groups, EN will be commenced as early as clinically feasible.
Primary outcomes Incidence of colestasis on Day 28 of admission.
Secondary outcomes are total plasma bilirrubine profiles, the incidence of hypoglycemia, hospital-acquired infections, length of hospital/NICU stay, in-hospital all-cause mortality, weight, height and head circumference.
Discussion: This RCT will examine the effects of NPTC versus late PNT in term and late preterm infants by comparing key biochemical and clinical outcomes and has the potential to identify underlying pathways for beneficial or harmful effects related to both treatments.
Trial registration: 2022.HPS.DI.434 (3rd March 2024)
Keywords: Parenteral nutrition cycling, Incidence of colestasis, incidence of hypoglycaemia, hospital-acquired infections, Randomised controlled trial.
150 studies on the registry are indexed under Cholestasis; 18 are open to participants now.
This study's planned enrollment of 66 is above the median of 53 across 90 interventional studies indexed under Cholestasis.
Browse Cholestasis studies →This is the only study on the registry with Hospital Pediátrico de Sinaloa as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: Parenteral nutrition cycling
This study is a single-centre, non-blinded RCT in the NICU of Pediatric Hospital of Sinaloa, Northwest, Mexico. A total of 66 infants born ≥34 weeks of gestation who have a high likelihood of intolerance to enteral nutrition (EN) for at least 10 days will be randomised to PNC o PNT after informed parental consent. In both groups, EN will be commenced as early as clinically feasible.
Also known as: Cyclic parenteral nutrition, Cycling parenteral nutrition, Cycle parenteral nutrition
Incidence of cholestasis on Day 28 of admission.
Proportion of cholestasis
Time frame: Day 1 to 28
are total plasma bilirrubine profiles
mg/dl
Time frame: Day 1 to 28
the incidence of hypoglycaemia
mg/dl
Time frame: Day 1 to 28
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.